Recombinant Human TRIM14 Protein, N-His

Reference: ARO-P11684
Size

100ug

Brand

Arovia

Product type

Recombinant Proteins

Product nameRecombinant Human TRIM14 Protein, N-His
Origin speciesHuman
Expression systemProkaryotic expression
Molecular weight23.77 kDa
BufferLyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
FormLiquid
Delivery conditionDry Ice
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandArovia
Host speciesEscherichia coli (E.coli)
Fragment TypeSer254-Pro442
Aliases /SynonymsKIAA0129, Tripartite motif-containing protein 14, TRIM14
ReferenceARO-P11684
NoteFor research use only.

Description of Recombinant Human TRIM14 Protein, N-His

Introduction to Recombinant Human TRIM14 Protein

Recombinant Human TRIM14 Protein, also known as Tripartite Motif Containing 14, is a protein that is encoded by the TRIM14 gene in humans. It belongs to the TRIM family of proteins, which are characterized by a tripartite motif consisting of a RING finger, B-box, and coiled-coil domain. TRIM14 is a multifunctional protein that plays a crucial role in various cellular processes, including immune response, cell signaling, and cancer development. In this article, we will discuss the structure, activity, and application of Recombinant Human TRIM14 Protein.

Structure of Recombinant Human TRIM14 Protein

The human TRIM14 protein is composed of 486 amino acids and has a molecular weight of approximately 55 kDa. It consists of three distinct domains: a RING finger domain at the N-terminus, two B-box domains in the middle, and a coiled-coil domain at the C-terminus. The RING finger domain is responsible for E3 ubiquitin ligase activity, while the B-box domains are involved in protein-protein interactions. The coiled-coil domain is responsible for the oligomerization of TRIM14, which is crucial for its function.

Recombinant Human TRIM14 Protein is produced by cloning the TRIM14 gene into a suitable expression vector and expressing it in a host cell, typically E. coli or mammalian cells. The resulting recombinant protein is then purified using various chromatography techniques to obtain a highly pure and active protein.

Activity of Recombinant Human TRIM14 Protein

Recombinant Human TRIM14 Protein has been shown to have multiple activities in various cellular processes. One of its main functions is its role as an E3 ubiquitin ligase, which is responsible for tagging proteins with ubiquitin for degradation by the proteasome. This function of TRIM14 is crucial for maintaining cellular homeostasis and regulating various signaling pathways.

In addition to its E3 ubiquitin ligase activity, TRIM14 also plays a role in innate immunity. It has been shown to interact with and regulate the activity of several immune-related proteins, such as NF-κB, IRF3, and STAT3. This activity of TRIM14 is important for the activation of immune responses and defense against pathogens.

Furthermore, Recombinant Human TRIM14 Protein has been implicated in cancer development and progression. It has been shown to interact with and regulate the activity of various oncogenes and tumor suppressor genes, leading to altered cell proliferation, survival, and migration. TRIM14 has also been found to be overexpressed in several types of cancer, making it a potential therapeutic target for cancer treatment.

Application of Recombinant Human TRIM14 Protein

The use of Recombinant Human TRIM14 Protein in research has been crucial in understanding its structure and function. Its recombinant form allows for easier purification and manipulation, making it an ideal protein for studying its role in various cellular processes. Additionally, recombinant TRIM14 can also be used in in vitro assays to study its E3 ubiquitin ligase activity and its interactions with other proteins.

Moreover, the potential therapeutic applications of Recombinant Human TRIM14 Protein are being explored. As mentioned earlier, TRIM14 has been implicated in cancer development and progression, making it a potential target for cancer treatment. Studies have shown that targeting TRIM14 can inhibit tumor growth and sensitize cancer cells to chemotherapy. Therefore, recombinant TRIM14 may have a future as a therapeutic agent for cancer treatment.

Conclusion

In summary, Recombinant Human TRIM14 Protein is a multifunctional protein with various activities in cellular processes such as immune response, cell signaling, and cancer development. Its

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Recombinant Human TRIM14 Protein, N-His”

Your email address will not be published. Required fields are marked *

Related products

Anti His tag mouse monoclonal antibody
Tag Antibody

Anti His tag mouse monoclonal antibody

PTX17851 180€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products